VERGELLI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 4.285
EU - Europa 3.833
AS - Asia 1.083
SA - Sud America 91
OC - Oceania 32
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.350
Nazione #
US - Stati Uniti d'America 4.278
PL - Polonia 1.868
RU - Federazione Russa 816
HK - Hong Kong 522
SG - Singapore 289
IT - Italia 276
IE - Irlanda 242
SE - Svezia 242
CN - Cina 99
GB - Regno Unito 86
BR - Brasile 79
UA - Ucraina 78
DE - Germania 77
FI - Finlandia 60
IN - India 43
VN - Vietnam 37
ID - Indonesia 33
AU - Australia 32
FR - Francia 30
JO - Giordania 25
BE - Belgio 23
CI - Costa d'Avorio 14
ES - Italia 13
TR - Turchia 12
NL - Olanda 10
CA - Canada 7
SC - Seychelles 4
AR - Argentina 3
CH - Svizzera 3
IQ - Iraq 3
RO - Romania 3
TN - Tunisia 3
BY - Bielorussia 2
EC - Ecuador 2
EG - Egitto 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BD - Bangladesh 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
JP - Giappone 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
PS - Palestinian Territory 1
PY - Paraguay 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 9.350
Città #
Warsaw 1.866
Santa Clara 1.203
Hong Kong 471
Fairfield 445
Chandler 289
Dublin 241
Seattle 218
Ashburn 217
Cambridge 178
Woodbridge 177
Houston 153
Singapore 148
Ann Arbor 144
Wilmington 134
Jacksonville 128
Florence 110
Altamura 88
Lawrence 83
Princeton 71
Buffalo 56
Boardman 40
Mumbai 38
Boston 37
Medford 37
Beijing 35
Jakarta 33
Melbourne 31
Dong Ket 27
Moscow 26
San Diego 26
Shanghai 26
Brussels 22
London 20
Los Angeles 20
Paris 20
New York 19
Abidjan 14
Barcelona 13
Hillsboro 12
Helsinki 10
Norwalk 10
West Jordan 10
Izmir 9
Phoenix 9
Yubileyny 9
Milan 8
Falls Church 7
Frankfurt Am Main 7
Kent 7
Fuzhou 6
São Paulo 6
Curitiba 5
Gavirate 5
Lappeenranta 5
Teresópolis 5
Toronto 5
Andover 4
Napoli 4
Philadelphia 4
Tappahannock 4
Auburn Hills 3
Baghdad 3
Belo Horizonte 3
Bern 3
Esslingen am Neckar 3
Menlo Park 3
Misano Adriatico 3
Porto Alegre 3
Pune 3
Scandicci 3
Verona 3
Zhengzhou 3
Amsterdam 2
Brumado 2
Carol Stream 2
Castelliri 2
Council Bluffs 2
Crawley 2
Dearborn 2
Fortaleza 2
Guangzhou 2
Lahore 2
Leawood 2
Manila 2
Mauá 2
Minsk 2
Munich 2
Prescot 2
Redwood City 2
Riyadh 2
Rui'an 2
Salerno 2
Shenzhen 2
Southwark 2
Tashkent 2
Timisoara 2
Trumbull 2
Tunis 2
Whitechapel 2
Al Ain City 1
Totale 7.146
Nome #
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 292
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 283
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 272
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 262
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 255
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 239
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 239
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 237
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 236
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 233
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 232
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 219
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 207
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 203
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 202
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 200
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 186
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 183
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 174
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 163
Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors 160
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 158
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 156
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 152
Cinnoline derivatives as human neutrophil elastase inhibitors 147
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. 142
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 137
4-AMINO-3(2H)-PYRIDAZINONES BEARING ARYLPIPERAZINYLALKYL GROUPS AND RELATED COMPOUNDS: SYNTHESIS AND ANTINOCICEPTIVE ACTIVITY 136
4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action 132
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action 131
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 126
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 126
New pyrazolo[1',5':1,6]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors 125
ISOXAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS LEISHMANIA MEXICANA PDE INHIBITORS 124
6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. 123
4-amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: synthesis, SARs, and preliminary studies on the mechanism of action 123
SELECTIVE ACAT INHIBITORS AS PROMISING ANTIHYPERLIPIDEMIC, ANTIATHEROSCLEROTIC AND ANTI-ALZHEIMER DRUGS 119
AIRWAY RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF A PDE 4 INHIBITOR WITH LOW AFFINITY FOR THE HIGH-AFFINITY ROLIPRAM BINDING SITE 118
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 114
NOVEL 3-ARYLAMINO- AND 3-CYCLOALKYLAMINO-5,6-DIPHENYLPYRIDAZINES ACTIVE AS ACAT INHIBITORS 113
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. 107
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 107
PDE5 Inhibitors and their applications 105
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 105
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 102
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 101
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 101
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 94
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 94
4-amino-5-vinyl-3(2H)-pyridazinones and related compounds: synthesis and evaluation of antinociceptive activity 91
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 88
preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 84
SYNTHESIS AND EVALUATION OF SOME PYRAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS PDE5 INHIBITORS POTENTIALLY USEFUL AS PERIPHERAL VASODILATOR 82
Preparation of pyridazin-3(2H)-ones and their use as PDE4 inhibitors 82
NEW SYNTHESIS OF DIFFERENTLY FUSED PYRIDAZINONQUINOLINES 81
Preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 80
Synthesis and evaluation of novel pyrrolo[2,3-d] and thieno[2,3-d]pyridazinones as in vitro antiproliferative agents 78
Alpha-2-agonist as analgesic agents 77
Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity agents as potential agents for treatment of erectile dysfunction 76
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 71
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 70
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 61
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 59
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 58
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 54
Pyridazin-3(2H)-one derivatives as novel PDE IV inhibitors 54
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 51
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 50
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 49
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 47
Totale 9.538
Categoria #
all - tutte 24.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020223 0 0 0 0 0 0 0 0 0 86 108 29
2020/20211.088 91 89 34 117 59 123 70 82 126 178 46 73
2021/2022508 16 34 40 17 17 32 17 36 20 39 121 119
2022/20231.232 123 271 47 102 99 207 153 65 99 5 42 19
2023/2024405 12 48 81 22 22 54 12 96 8 27 16 7
2024/20253.250 123 324 173 470 1.000 467 63 161 395 74 0 0
Totale 9.538